Masci, Domiziana
 Distribuzione geografica
Continente #
EU - Europa 310
NA - Nord America 297
AS - Asia 173
AF - Africa 3
OC - Oceania 1
Totale 784
Nazione #
US - Stati Uniti d'America 297
SE - Svezia 129
SG - Singapore 95
IT - Italia 79
CN - Cina 35
IE - Irlanda 32
ID - Indonesia 31
RU - Federazione Russa 18
DE - Germania 17
GB - Regno Unito 8
FI - Finlandia 7
FR - Francia 6
NL - Olanda 5
CZ - Repubblica Ceca 4
IR - Iran 4
TR - Turchia 4
AT - Austria 3
IN - India 3
EG - Egitto 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 784
Città #
Chandler 94
Singapore 78
Rome 34
Jakarta 31
Dublin 30
Ashburn 20
Moscow 18
Princeton 16
San Mateo 14
Boston 11
Munich 8
Andover 6
Aprilia 6
Augusta 6
Hangzhou 6
Helsinki 5
Los Angeles 5
Milan 5
Istanbul 4
Kish 4
Wilmington 4
Beijing 3
Brno 3
London 3
Paris 3
Washington 3
Blackrock 2
Cairo 2
Cattolica 2
Guidonia Montecelio 2
Lappeenranta 2
New York 2
Pavia 2
Seattle 2
Siena 2
Slough 2
Vienna 2
Albuquerque 1
Bratislava 1
Calvisano 1
Coimbra 1
Delhi 1
Dubai 1
East Brunswick 1
Genoa 1
Groningen 1
Guangzhou 1
Houston 1
Kozhikode 1
Mountain View 1
North Bergen 1
Nuremberg 1
Olomouc 1
Palakkad 1
Santa Maria Capua Vetere 1
Sousse 1
Tivoli 1
Xi'an 1
Totale 463
Nome #
Small molecule inhibitors of kdm5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B 53
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 52
Biocatalytic aromatization of indolines into indoles by monoamine oxidase (MAO-N) whole cells 46
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors 45
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 39
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 39
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria 37
CHAPTER 4. Biocatalysis, an Introduction. Exploiting Enzymes as Green Catalysts in the Synthesis of Chemicals and Drugs 36
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 36
Monoamine Oxidase (MAO-N) Biocatalyzed Synthesis of Indoles from Indolines Prepared via Photocatalytic Cyclization/Arylative Dearomatization 35
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities 34
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 33
A facile and regioselective multicomponent synthesis of chiral aryl-1,2-mercaptoamines in water followed by monoamine oxidase (MAO-N) enzymatic resolution 33
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents 32
Indolylarylsulfones as novel potent anti-HIV-1 agents 29
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studies 27
Biocatalytic and Chemo-Enzymatic Approaches for the Synthesis of Heterocycles 27
Indolylarylsulfones as novel potent anti-HIV-1 agents 25
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 19
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 14
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo 13
Oxidative Cysteine Post Translational Modifications Drive the Redox Code Underlying Neurodegeneration and Amyotrophic Lateral Sclerosis 11
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment 11
Food-inspired peptides from spinach Rubisco endowed with antioxidant, antinociceptive and anti-inflammatory properties 11
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor 11
Liposome-siderophore conjugates loaded with moxifloxacin serve as a model for drug delivery against Mycobacterium tuberculosis 10
Lycopene enriched extra virgin olive oil: Biological activities and assessment of security profile on cells 9
Emerging Direct Targeting β-Catenin Agents 9
Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators 7
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy 7
Valorization of grape pomace extracts against cranberry, elderberry, rose hip berry, goji berry and raisin extracts: Phytochemical profile and in vitro biological activity 7
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral Administration 7
Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation 7
Discovery of Benzopyrone-Based Candidates as Potential Antimicrobial and Photochemotherapeutic Agents through Inhibition of DNA Gyrase Enzyme B: Design, Synthesis, In Vitro and In Silico Evaluation 6
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor 6
Valorisation of Side Stream Products through Green Approaches: The Rapeseed Meal Case 5
Targeting CBP and p300: Emerging Anticancer Agents 5
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability 4
Totale 837
Categoria #
all - tutte 6.485
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022129 0 0 0 0 0 0 0 68 9 1 31 20
2022/2023309 55 32 29 6 40 36 12 35 49 1 9 5
2023/2024202 6 50 5 7 6 15 5 3 17 7 44 37
2024/2025197 16 5 45 53 78 0 0 0 0 0 0 0
Totale 837